Annual Southern California Pituitary Symposium at USC

Saturday, October 28, 2023, 8:00 AM - 2:40 PM, Aresty Conference Center - USC Health Sciences Campus, Los Angeles, CA

AMA PRA Category 1 Credits™ (5.25 hours), Non-Physician Attendance (5.25 hours)

1. Illustrate the general principles of diagnosis, treatment and management of pituitary tumors, including acromegaly, Cushing's disease, prolactinomas and nonfunctioning pituitary tumors.
2. Evaluate and select the appropriate diagnostic test to confirm the diagnosis of pituitary tumors and related pituitary disorders.
3. Recognize the difficulties in the diagnosis and interpretation of test results in pituitary rumors and related pituitary disorders.
4. Describe the clinical, radiologic and pathological definition of an aggressive pituitary tumor and discuss management options for patients.
5. Review the anatomy of the pituitary region and anterior skull base and discuss the advantages of endoscopic endonasal surgery for pituitary tumors.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 5.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy

Cancellations must be received by the USC Office of CME by email only by October 24, 2023 at 12:00 pm PDT for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, October 28, 2023

Gratefully Acknowledges Educational Support

 

Recordati Rare Diseases

 

Corcept Therapeutics

 

Xeris Pharmaceuticals